Table of Contents:
I. I. NIDA Imaging Genetics Webinar Series
I. NIDA Imaging Genetics Webinar Series
NIDA is pleased to webcast its weekly series on Imaging Genetics starting January 21, 2016 and ending March 24, 2016. To join see instructions below. The invited speakers are
Jan 21. Ahmad Hariri, Functional Neuroimaging Targets for the Genetic Dissection of Substance Abuse Risk
Jan 28. Sarah Medland, Identifying genetic variants associated with human brain structure: work from the ENIGMA consortium
Feb 4. Jason Stein, Evaluating the overlap between common genetic variants influencing brain structure and neuropsychiatric diseases
Feb 11. Elliot Stein, Imaging genetic insights into nicotine addiction
Feb 18. Kerry Ressler, Neural Mechanisms at the Intersection of Trauma, Fear, Habits and Addiction
Feb 25. David Glahn, A Family-Based Approach to Imaging Genetics of Addiction and Comorbid Mental Illness
Mar 3. Neda Jahanshad, Neuroimaging genetics of the human structural connectome
Mar 10. Hao Yang, Imaging Genetics of Schizophrenia/Psychosis
Mar 17. Barbara Franke, Cognomics: from gene-finding to understanding the biology underlying psychiatric disorders
Mar 24. Anand Mattay, Genetics of Cognitive Aging
Meeting number: 620 321 515
Meeting password: Nidagenetics1!
Join by phone
1-877-668-4493 Call-in toll-free number (US/Canada)
1-650-479-3208 Call-in toll number (US/Canada)
Access code: 620 321 515
Add this meeting to your calendar. (Cannot add from mobile devices.)
Can't join the meeting? Contact support. (Please contact support if you are using Windows 10)
Please send me an email so I can send a calendar invite as a reminder. firstname.lastname@example.org
II. II. Marijuana and Cannabinoids: A Neuroscience Research Summit, March 22-23, 2016, Natcher Conference Center, NIH, Bethesda, MD
III. The Marijuana and Cannabinoids: A Neuroscience Research Summit is being convened on March 22-23 by the National Institutes of Health. The Research Summit will focus on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system will be addressed. The event will be held at the Natcher Conference Center on the NIH campus in Bethesda, Maryland.
We encourage you to register as soon as possible as we expect a high volume of interest. Please note there is no registration fee. In addition, we are seeking abstracts for scientific poster sessions to be held during the Summit. Deadline for submission is January 19th with selections made by February 1st.
For further information about the Summit, registration, logistics, and scientific poster abstract submissions, please Click Here. Information will be added on a rolling basis so please check regularly for updates.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to email@example.com Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact firstname.lastname@example.org 301-435-1309